[Form 4] AngioDynamics, Inc. Insider Trading Activity

Rhea-AI Filing Summary

SEC Form 4 – AngioDynamics (ANGO)

Laura Piccinini, SVP International, disposed of 3,074 common shares on 17 Jul 2025. The shares were automatically withheld at $8.74 per share (≈ $26.9 k) to satisfy tax obligations tied to the scheduled vesting of restricted stock units granted on 17 Jul 2024. After the exempt disposition, Piccinini continues to hold 69,355 directly owned shares. No derivative security activity was reported.

The transaction is classified under code “F,” indicating a tax-withholding event rather than an open-market sale, and therefore is generally viewed as administratively routine with limited impact on the company’s share supply or insider sentiment.

Insights

Financial Analyst

TL;DR: Routine tax-withholding share sale—neutral impact on ANGO.

The filing records an exempt disposition to cover payroll taxes upon RSU vesting. Only 3,074 shares (sub-$30 k value) changed hands, leaving the executive’s ownership largely intact at 69,355 shares. Such F-code transactions are administrative, do not represent discretionary selling pressure, and typically carry no valuation signal. Consequently, I view the event as non-impactful for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Piccinini Laura

(Last) (First) (Middle)

14 PLAZA DRIVE

(Street)

LATHAM NY 12110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP International

3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/17/2025		F		3,074(1)	D	$8.74	69,355	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The exempt disposition of 3,074 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024

	/s/ Lawrence T. Weiss, Attorney in Fact	07/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ANGO shares did SVP Laura Piccinini dispose of on 17 Jul 2025?

She disposed of 3,074 common shares.

What was the price per share for the tax-withholding transaction?

The shares were valued at $8.74 each.

How many ANGO shares does Piccinini own after the Form 4 transaction?

She directly owns 69,355 shares following the filing.

Was the transaction an open-market sale?

No. It was coded "F," indicating shares withheld solely to cover taxes on RSU vesting.